These results suggest that miR-30c-2-3p inhibits RCC cell proliferation and promotes apoptosis by regulating TOP2A expression and, subsequently, by triggering Fas/FasL/caspase 8/caspase 3. This evidence concerns the gene FAS and renal cell carcinoma.